Format

Send to

Choose Destination
Bioorg Med Chem Lett. 2012 Sep 15;22(18):5948-51. doi: 10.1016/j.bmcl.2012.07.062. Epub 2012 Jul 22.

N-Benzoyl anthranilic acid derivatives as selective inhibitors of aldo-keto reductase AKR1C3.

Author information

1
Institute of Biochemistry, Medical Faculty, University of Ljubljana, Ljubljana, Slovenia.

Abstract

Human aldo-keto reductases AKR1C1-AKR1C3 are involved in the biosynthesis and inactivation of steroid hormones and prostaglandins and thus represent attractive targets for the development of new drugs. We synthesized a series of N-benzoyl anthranilic acid derivatives and tested their inhibitory activity on AKR1C enzymes. Our data show that these derivatives inhibit AKR1C1-AKR1C3 isoforms with low micromolar potency. In addition, five selective inhibitors of AKR1C3 were identified. The most promising inhibitors were compounds 10 and 13, with IC(50) values of 0.31 μM and 0.35 μM for AKR1C3, respectively.

PMID:
22897946
PMCID:
PMC4038446
DOI:
10.1016/j.bmcl.2012.07.062
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center